Zeria Pharmaceutical Co Ltd
TSE:4559
Gross Margin
Zeria Pharmaceutical Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | JP |
| Market Cap | 88.2B JPY |
| Gross Margin |
73%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 744.3B USD |
| Gross Margin |
80%
|
| Country | DK |
| Market Cap | 4T DKK |
| Gross Margin |
85%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | US |
| Market Cap | 364.1B USD |
| Gross Margin |
70%
|
| Country | US |
| Market Cap | 331.8B USD |
| Gross Margin |
75%
|
| Country | UK |
| Market Cap | 187.5B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 189B CHF |
| Gross Margin |
73%
|
| Country | CH |
| Market Cap | 182.7B CHF |
| Gross Margin |
74%
|
| Country | US |
| Market Cap | 161.7B USD |
| Gross Margin |
70%
|
Profitability Report
View the profitability report to see the full profitability analysis for Zeria Pharmaceutical Co Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Zeria Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 73.3%.
You don't have any saved screeners yet
